Advagraf 3 mg

ADVAGRAF 3 MG capsules are an extended-release formulation of tacrolimus, used to prevent organ rejection post-transplant. This immunosuppressant helps maintain transplant success by reducing immune system activity.

ADVAGRAF 3 MG capsules are primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. Tacrolimus works by suppressing the immune system, allowing the body to accept the transplanted organ. This medication is often prescribed as part of a broader treatment plan to ensure the success of the transplant procedure.

Common effects of ADVAGRAF 3 MG may include tremors, headaches, and gastrointestinal issues such as nausea or diarrhea. Some individuals might experience changes in kidney function or blood pressure. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

ADVAGRAF 3 MG should be handled with care, as it is an immunosuppressant. Patients should avoid activities that increase the risk of infection and follow a balanced diet to support overall health. Regular blood tests may be required to monitor kidney function and drug levels in the blood.

ADVAGRAF 3 MG may interact with various medications, including certain antibiotics, antifungals, and anticonvulsants. Grapefruit and grapefruit juice should be avoided, as they can affect how the body processes tacrolimus. Always inform healthcare providers about all medications being taken to avoid potential interactions.